Neuphoria Therapeutics Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| NEUP | NMRA | ABVC | NSB.AX | ALZN | SILO | |
|---|---|---|---|---|---|---|
| Market cap | 16.13M | 106.35M | 26.69M | 21.04M | 7.38M | 2.93M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -1.2 | -0.9 | -2.3 | — | -1.8 | -1.9 |
| Price/book | 0.7 | 2.4 | 2.5 | 1.4 | 1.3 | 0.3 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −32.05% | −78.21% | −64.79% | −65.52% | −39.29% | −82.01% |
| Today | −0.33% | −0.86% | +1.51% | 0.00% | +4.79% | +3.91% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.
Latest news
All NEUP news ›Neuphoria Therapeutics (NASDAQ:NEUP) & Sera Prognostics (NASDAQ:SERA) Financial Review
Posted by Defense World Staff on Oct 19th, 2026 Sera Prognostics (NASDAQ:SERA – Get Free Report) and Neuphoria Therapeutics (NASDAQ:NEUP – Get Free Report) are both small-cap healthcare companies, but which is the superior business? We…
Co-Diagnostics (NASDAQ:CODX) versus Neuphoria Therapeutics (NASDAQ:NEUP) Head to Head Comparison
Posted by Sarita Garza on Oct 12th, 2026 Neuphoria Therapeutics (NASDAQ:NEUP – Get Free Report) and Co-Diagnostics (NASDAQ:CODX – Get Free Report) are both small-cap healthcare companies, but which is the better investment? We will compare…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- defenseworld.net1
- themarketsdaily.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.